Table 3.
Pathogens Identified in Patients Hospitalized for COVID-19 and a Coinfectiona
| Community-Onset | No. (%) | Hospital-Acquired | No. (%) |
|---|---|---|---|
| Pathogen | (N=71) | Pathogen | (N=79) |
| Respiratory infection | |||
| Staphylococcus aureus | Staphylococcus aureus | ||
| MSSA | 9 (12.7) | MSSA | 14 (17.7) |
| MRSA | 5 (7.0) | MRSA | 14 (17.7) |
| Streptococcus | Pseudomonas | 10 (12.7) | |
| S. pneumoniae | 3 (4.2) | Escherichia coli | 4 (5.1) |
| S. anginosus | 1 (1.4) | Streptococcus | |
| S. viridians | 1 (1.4) | S. pneumoniae | 2 (2.5) |
| Other | 2 (2.8) | S. anginosus | 1 (1.3) |
| Haemophilus | 3 (4.2) | Other | 1 (1.3) |
| Escherichia coli | 2 (2.8) | Haemophilus | 3 (3.8) |
| Aspergillus | 2 (2.8) | Enterobacter | 3 (3.8) |
| Pseudomonas | 2 (2.8) | Klebsiella | 3 (3.8) |
| Legionella | 2 (2.8) | Stenotrophomonas | 2 (2.5) |
| Citrobacter | 1 (1.4) | Proteus | 1 (1.3) |
| Klebsiella | 1 (1.4) | Aspergillus | 1 (1.3) |
| Mycoplasma | 1 (1.4) | Legionella b | 1 (1.3) |
| Moraxella | 1 (1.3) | ||
| Bloodstream infection | |||
| Staphylococcus aureus | Coagulase-negative Staphylococcus | 6 (7.6) | |
| MSSA | 6 (8.5) | Staphylococcus aureus | |
| MRSA | 5 (7.0) | MSSA | 3 (3.8) |
| Escherichia coli | 5 (7.0) | MRSA | 2 (2.5) |
| Enterococcus faecalis | 4 (5.6) | Enterococcus | |
| Acinetobacter | 3 (4.2) | E. faecium | 2 (2.5) |
| Pseudomonas | 3 (4.2) | E. faecalis | 1 (1.3) |
| Bacteroides | 2 (2.8) | Candida | 2 (2.5) |
| Haemophilus | 2 (2.8) | Escherichia coli | 1 (1.3) |
| Klebsiella | 2 (2.8) | Streptococcus anginosus | 1 (1.3) |
| Proteus | 2 (2.8) | ||
| Coagulase-negative Staphylococcus | 1 (1.4) | ||
| Streptococcus group B | 1 (1.4) |
Note. MSSA, methicillin-susceptible Staphylococcus aureus; MRSA, methicillin-resistant Staphylococcus aureus.
a
First infection only, some patients with multiple pathogens.
b
Legionella case met CDC criteria for possible healthcare-associated infection.